お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はライソゾーム蓄積性疾患市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはライソゾーム蓄積性疾患の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のライソゾーム蓄積性疾患市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはライソゾーム蓄積性疾患のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にライソゾーム蓄積性疾患市場を分類しています。本研究に含まれる主な企業は：Actelion Pharmaceuticals、BioMarin、Genzyme、Takeda、Alexion Pharmaceuticals、Amicus Therapeutics、Chiesi Farmaceutici、Greenovation Biotech And FGK Clinical Research、Horizon Pharma、Leadiant Biosciences、Mylan

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Enzyme Replacement Therapy
    Substrate Reduction Therapy
    Cystine Depleting Agents

用途別の市場セグメント：
    Hospitals
    Ambulatory Surgical Centers

本レポートの詳細内容
世界のライソゾーム蓄積性疾患市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、ライソゾーム蓄積性疾患タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のライソゾーム蓄積性疾患収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のライソゾーム蓄積性疾患市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、ライソゾーム蓄積性疾患市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

ライソゾーム蓄積性疾患のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：ライソゾーム蓄積性疾患のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：ライソゾーム蓄積性疾患の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章ライソゾーム蓄積性疾患企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：ライソゾーム蓄積性疾患の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：ライソゾーム蓄積性疾患の主要企業の概要を提供し、製品の説明と仕様、ライソゾーム蓄積性疾患の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.

Market Analysis and Insights: Global Lysosomal Storage Diseases Market
The global Lysosomal Storage Diseases market is projected to grow from US$ 7847.7 million in 2024 to US$ 10460 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period.
According to the report, one driver in the market is unmet medical needs.

Report Covers:
This report presents an overview of global market for Lysosomal Storage Diseases market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Lysosomal Storage Diseases, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Lysosomal Storage Diseases, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lysosomal Storage Diseases revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Lysosomal Storage Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Lysosomal Storage Diseases revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Actelion Pharmaceuticals, BioMarin, Genzyme, Takeda, Alexion Pharmaceuticals, Amicus Therapeutics, Chiesi Farmaceutici, Greenovation Biotech And FGK Clinical Research and Horizon Pharma, etc.

Market Segmentation
By Company
    Actelion Pharmaceuticals
    BioMarin
    Genzyme
    Takeda
    Alexion Pharmaceuticals
    Amicus Therapeutics
    Chiesi Farmaceutici
    Greenovation Biotech And FGK Clinical Research
    Horizon Pharma
    Leadiant Biosciences
    Mylan

Segment by Type
    Enzyme Replacement Therapy
    Substrate Reduction Therapy
    Cystine Depleting Agents

Segment by Application
    Hospitals
    Ambulatory Surgical Centers

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Lysosomal Storage Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lysosomal Storage Diseases companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lysosomal Storage Diseases revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Lysosomal Storage Diseases Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Enzyme Replacement Therapy
    Table 3. Key Players of Substrate Reduction Therapy
    Table 4. Key Players of Cystine Depleting Agents
    Table 5. Global Lysosomal Storage Diseases Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Lysosomal Storage Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Lysosomal Storage Diseases Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Lysosomal Storage Diseases Market Share by Region (2019-2024)
    Table 9. Global Lysosomal Storage Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Lysosomal Storage Diseases Market Share by Region (2025-2030)
    Table 11. Lysosomal Storage Diseases Market Trends
    Table 12. Lysosomal Storage Diseases Market Drivers
    Table 13. Lysosomal Storage Diseases Market Challenges
    Table 14. Lysosomal Storage Diseases Market Restraints
    Table 15. Global Lysosomal Storage Diseases Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Lysosomal Storage Diseases Revenue Share by Players (2019-2024)
    Table 17. Global Top Lysosomal Storage Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2023)
    Table 18. Global Lysosomal Storage Diseases Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Lysosomal Storage Diseases Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Lysosomal Storage Diseases, Headquarters and Area Served
    Table 21. Global Key Players of Lysosomal Storage Diseases, Product and Application
    Table 22. Global Key Players of Lysosomal Storage Diseases, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Lysosomal Storage Diseases Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Lysosomal Storage Diseases Revenue Market Share by Type (2019-2024)
    Table 26. Global Lysosomal Storage Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Lysosomal Storage Diseases Revenue Market Share by Type (2025-2030)
    Table 28. Global Lysosomal Storage Diseases Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Lysosomal Storage Diseases Revenue Share by Application (2019-2024)
    Table 30. Global Lysosomal Storage Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Lysosomal Storage Diseases Revenue Share by Application (2025-2030)
    Table 32. North America Lysosomal Storage Diseases Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Lysosomal Storage Diseases Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Lysosomal Storage Diseases Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Lysosomal Storage Diseases Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Lysosomal Storage Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Lysosomal Storage Diseases Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Lysosomal Storage Diseases Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Lysosomal Storage Diseases Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Lysosomal Storage Diseases Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Lysosomal Storage Diseases Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Lysosomal Storage Diseases Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Lysosomal Storage Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Lysosomal Storage Diseases Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Lysosomal Storage Diseases Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Lysosomal Storage Diseases Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Lysosomal Storage Diseases Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Lysosomal Storage Diseases Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Lysosomal Storage Diseases Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Lysosomal Storage Diseases Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Lysosomal Storage Diseases Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Lysosomal Storage Diseases Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Lysosomal Storage Diseases Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Lysosomal Storage Diseases Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Lysosomal Storage Diseases Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Lysosomal Storage Diseases Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Lysosomal Storage Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Actelion Pharmaceuticals Company Details
    Table 65. Actelion Pharmaceuticals Business Overview
    Table 66. Actelion Pharmaceuticals Lysosomal Storage Diseases Product
    Table 67. Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 68. Actelion Pharmaceuticals Recent Developments
    Table 69. BioMarin Company Details
    Table 70. BioMarin Business Overview
    Table 71. BioMarin Lysosomal Storage Diseases Product
    Table 72. BioMarin Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 73. BioMarin Recent Developments
    Table 74. Genzyme Company Details
    Table 75. Genzyme Business Overview
    Table 76. Genzyme Lysosomal Storage Diseases Product
    Table 77. Genzyme Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 78. Genzyme Recent Developments
    Table 79. Takeda Company Details
    Table 80. Takeda Business Overview
    Table 81. Takeda Lysosomal Storage Diseases Product
    Table 82. Takeda Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 83. Takeda Recent Developments
    Table 84. Alexion Pharmaceuticals Company Details
    Table 85. Alexion Pharmaceuticals Business Overview
    Table 86. Alexion Pharmaceuticals Lysosomal Storage Diseases Product
    Table 87. Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 88. Alexion Pharmaceuticals Recent Developments
    Table 89. Amicus Therapeutics Company Details
    Table 90. Amicus Therapeutics Business Overview
    Table 91. Amicus Therapeutics Lysosomal Storage Diseases Product
    Table 92. Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 93. Amicus Therapeutics Recent Developments
    Table 94. Chiesi Farmaceutici Company Details
    Table 95. Chiesi Farmaceutici Business Overview
    Table 96. Chiesi Farmaceutici Lysosomal Storage Diseases Product
    Table 97. Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 98. Chiesi Farmaceutici Recent Developments
    Table 99. Greenovation Biotech And FGK Clinical Research Company Details
    Table 100. Greenovation Biotech And FGK Clinical Research Business Overview
    Table 101. Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Product
    Table 102. Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 103. Greenovation Biotech And FGK Clinical Research Recent Developments
    Table 104. Horizon Pharma Company Details
    Table 105. Horizon Pharma Business Overview
    Table 106. Horizon Pharma Lysosomal Storage Diseases Product
    Table 107. Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 108. Horizon Pharma Recent Developments
    Table 109. Leadiant Biosciences Company Details
    Table 110. Leadiant Biosciences Business Overview
    Table 111. Leadiant Biosciences Lysosomal Storage Diseases Product
    Table 112. Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 113. Leadiant Biosciences Recent Developments
    Table 114. Mylan Company Details
    Table 115. Mylan Business Overview
    Table 116. Mylan Lysosomal Storage Diseases Product
    Table 117. Mylan Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
    Table 118. Mylan Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lysosomal Storage Diseases Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Lysosomal Storage Diseases Market Share by Type: 2023 VS 2030
    Figure 3. Enzyme Replacement Therapy Features
    Figure 4. Substrate Reduction Therapy Features
    Figure 5. Cystine Depleting Agents Features
    Figure 6. Global Lysosomal Storage Diseases Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Lysosomal Storage Diseases Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals Case Studies
    Figure 9. Ambulatory Surgical Centers Case Studies
    Figure 10. Lysosomal Storage Diseases Report Years Considered
    Figure 11. Global Lysosomal Storage Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Lysosomal Storage Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Lysosomal Storage Diseases Market Share by Region: 2023 VS 2030
    Figure 14. Global Lysosomal Storage Diseases Market Share by Players in 2023
    Figure 15. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Lysosomal Storage Diseases Revenue in 2023
    Figure 17. North America Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Lysosomal Storage Diseases Market Share by Type (2019-2030)
    Figure 19. North America Lysosomal Storage Diseases Market Share by Application (2019-2030)
    Figure 20. North America Lysosomal Storage Diseases Market Share by Country (2019-2030)
    Figure 21. United States Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Lysosomal Storage Diseases Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Lysosomal Storage Diseases Market Share by Type (2019-2030)
    Figure 25. Europe Lysosomal Storage Diseases Market Share by Application (2019-2030)
    Figure 26. Europe Lysosomal Storage Diseases Market Share by Country (2019-2030)
    Figure 27. Germany Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Lysosomal Storage Diseases Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Lysosomal Storage Diseases Market Share by Type (2019-2030)
    Figure 35. China Lysosomal Storage Diseases Market Share by Application (2019-2030)
    Figure 36. Asia Lysosomal Storage Diseases Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Lysosomal Storage Diseases Market Share by Type (2019-2030)
    Figure 38. Asia Lysosomal Storage Diseases Market Share by Application (2019-2030)
    Figure 39. Asia Lysosomal Storage Diseases Market Share by Region (2019-2030)
    Figure 40. Japan Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Share by Country (2019-2030)
    Figure 50. Brazil Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 57. BioMarin Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 58. Genzyme Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 59. Takeda Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 60. Alexion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 61. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 62. Chiesi Farmaceutici Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 63. Greenovation Biotech And FGK Clinical Research Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 64. Horizon Pharma Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 65. Leadiant Biosciences Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 66. Mylan Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed